4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-22-014471
EVP, Chief Financial Officer acquired 18,430 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kalif Eliyahu Sharon · EVP, Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-28 | Exercise or conversion : show line 1 in the form | +18,430 | 43,489 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-28 | Exercise or conversion : show line 2 in the form Restricted Share Units | −18,430 | 36,860 | D |
Loading xslF345X03/doc4.xml…